-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Whether proton pump inhibitors (PPI) can improve the blood sugar control of diabetic patients or reduce the risk of diabetes in the general population is not yet clear
diabetes
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
The researchers searched PubMed, Embase, Scopus and ClinicalTrials.
PPI treatment and the relative risk of diabetes
The systematic review included seven blood glucose control studies (n=342) and five studies that assessed the risk of diabetes (n=244439)
It can be seen that receiving PPI treatment improved the glycemic index of diabetic patients, but did not change the risk of diabetes
PPI treatment improved the glycemic index of diabetic patients, but did not change the risk of diabetes
Original source:
Carol Chiung-Hui Peng.
Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-Analysis
In this message